about
Co-inheritance of haemoglobin A2' and beta-thalassaemia in cis.Paired measurement of urinary creatinine in neonates based on a Jaffe and an enzymatic IDMS-traceable assayEvaluation of the first commercial hepcidin ELISA for the differential diagnosis of anemia of chronic disease and iron deficiency anemia in hospitalized geriatric patients.Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodelingFactors impacting unbound vancomycin concentrations in different patient populations.Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay.Prevalence and clinical significance of rare antinuclear antibody patterns.A prospective randomized open-label crossover trial of regional citrate anticoagulation vs. anticoagulation free liver dialysis by the Molecular Adsorbents Recirculating System.Role of Glucagon in Catabolism and Muscle Wasting of Critical Illness and Modulation by Nutrition.Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.Cefazolin plasma protein binding and its covariates in neonates.Sustained endothelial progenitor cell dysfunction after chronic hypoxia-induced pulmonary hypertension.Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays.Pharmacokinetics of Posaconazole Oral Suspension in Children Dosed According to Body Surface Area.Renal function in children and adolescents with Duchenne muscular dystrophy.Implementation of a companion diagnostic in the clinical laboratory: the BRAF example in melanoma.Isolated sulfite oxidase deficiency.L-arginine administration reduces neointima formation after stent injury in rats by a nitric oxide-mediated mechanism.Minimal interference from paricalcitol (ZemplarĀ®) in underivatized 1,25-dihydroxyvitamin D LC-MS/MS assays.Localization, etiology and impact of calcium phosphate deposits in renal allografts.Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.Preexisting antiadenoviral immunity and regional myocardial gene transfer: modulation by nitric oxide.Evidence for Bone and Mineral Metabolism Alterations in Children With Autosomal Dominant Polycystic Kidney Disease.Comparison of membrane affinity-based method with size-exclusion chromatography for isolation of exosome-like vesicles from human plasma.Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.The C6 Lyme antibody test has low sensitivity for antibody detection in cerebrospinal fluid.Improving quality in the preanalytical phase through innovation, on behalf of the European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for Preanalytical Phase (WG-PRE).Right ventricular fatigue developing during endurance exercise: an exercise cardiac magnetic resonance study.IgM interference in the Abbott iVanco immunoassay: A case report.ADAMTS5 deficiency protects against non-alcoholic steatohepatitis in obesity.Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.Practice-oriented quality specifications for therapeutic drug monitoring.Anti-PM/Scl-100 and anti-RNA-polymerase III antibodies in scleroderma.A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy)Free Testosterone Reflects Metabolic as well as Ovarian Disturbances in Subfertile Oligomenorrheic WomenPersonalized laboratory medicine: a patient-centered future approachAppropriateness of ordering serum angiotensin-converting enzyme during renin-angiotensin-aldosterone system inhibitor therapyMeasuring Rates of ATP SynthesisAdrenocortical function during prolonged critical illness and beyond: a prospective observational studyHeterogeneous nuclear RNPs as targets of autoantibodies in systemic rheumatic diseases
P50
Q29353914-3EA283ED-7CE5-43AD-9211-78132DACE003Q35147367-1CE055FE-0579-496B-8326-5FD27C89DCCCQ35825545-6BD53BF4-7F18-46CE-A735-559D56D29EDFQ36012729-14CE99B3-5729-4047-865D-0EFA1F72C69AQ36158421-DBFA10A8-358C-4A01-9990-01A0CD1222B7Q37899393-3AD9E303-F5B0-4261-B1B5-83B6B4A241F5Q38098828-52610739-6D73-4AE2-99CB-A4586DFD12B6Q38460284-6E32212B-ED54-45FF-A4DD-031DC6E59F42Q38802352-0715681F-FFA1-4556-9EC4-A5F4295A68AEQ39553916-CE835B40-92C4-49A6-8588-C7CEF1D18B39Q39579691-C153BBBC-F7E4-4A4E-BA96-08C62C044AD1Q40125970-628258D4-B615-4DC1-8049-DEC0271DC0B5Q40591994-17B43870-5569-4272-A6B5-2DCBB99560C9Q40919715-36B57CD4-EB7D-4BD0-AC7C-58BF841DE57AQ41482471-041E0E9A-48EC-49D0-AE3D-227EF6F747E4Q41749375-2D3EDA89-ACC0-4DF1-A1E6-4F0031BD3069Q41918146-20146C6B-E800-47F7-B40A-DFF40CCC50DBQ43764590-5FEC32A3-718A-40AF-A08E-C20E6935D7F1Q43832518-74E0336B-4FCD-495A-9A7F-4697A8622302Q44432001-FAFF42CB-5CFA-41E3-AE17-84947CE7C2DDQ44814453-E7B3EDF9-4CA3-47DE-A470-68430976189EQ45858017-0856D945-DEBD-4D6F-B81B-E761973AB12DQ46274019-95314067-8E07-4FF4-BA81-8651EE5C24C0Q47216517-1A95E4F4-49BB-4EC3-BEF2-483FC1B3A2BDQ47273911-7CA4B75F-B24F-4AEB-BEDC-BE9E5D20DA58Q47986330-35572DED-3AB9-45D3-80FA-66EA1CE2E097Q48202374-281412B9-FD30-4FA9-A5A1-75E094EC186EQ48598056-3927EDA2-8D4D-4CF4-A643-CDFF2CD90B46Q49138637-FA1D7986-8866-4531-8D5E-8602B7E043DBQ50803490-2CF83490-838D-462B-96D9-21E425735A08Q53417981-B4C89BBF-3DC0-4F5F-9F42-9AB716980D60Q54489946-A7096D62-321E-40FB-A2F5-C385D6EEA889Q54684347-71CCF909-9AE0-4003-9B54-D7541BDA5124Q57052336-5574C251-618D-445D-9F50-85147602CAF8Q57114491-89097BA6-9ADE-4436-9A5E-82C457865EF1Q57176546-1E62C544-EB76-4146-BC18-6ECEAE6A09D9Q57297388-1A3CA7EE-073A-4013-919B-86E2B011AB4DQ57454755-F4DEC054-3DCA-4A97-ACD4-3A7A6E30EA79Q58742103-26D29405-E0A7-4053-B938-FE362AED9C86Q62649466-53733D63-3DEB-46FE-9C54-7D9B5CF2B5C3
P50
description
researcher
@en
wetenschapper
@nl
name
P Vermeersch
@en
P Vermeersch
@nl
type
label
P Vermeersch
@en
P Vermeersch
@nl
prefLabel
P Vermeersch
@en
P Vermeersch
@nl
P106
P31
P496
0000-0001-7076-061X